Brinzeu, Andrei http://orcid.org/0000-0002-2073-9123
Berthiller, Julien
Perreton, Nathalie
Subtil, Fabien
Gervaise, Caroline
Luaute, Jacques
Mertens, Patrick
,
Lanteri-Minet, Michel
Perrouin Verbe, Brigitte
Jarraya, Bechir
Menei, Philippe
Voirin, Jimmy
Regis, Jean-Marie
Buffenoir, Kevin
Lefort, Marc
Fontaine, Denys
Barat, Jean Luc
Article History
Received: 26 April 2024
Accepted: 6 August 2024
First Online: 7 September 2024
Declarations
:
: The study protocol was submitted as per French regulation for ethics approval to the Comité de Protection des Personnes CPP (the Comithee for the Protection of Persons – French Public Ethics Committee) Sud Est et outre-Mer which approved it on November 7th, 2019, with the reference number 2019-038-id3583. Its agreement was transferred to the Agence Nationale de la Surete Medicamenteuse—National Agency for Drugs and Medical Device Safety who gave the final approval for the conduct of the study on May 16th, 2019 (2019–001406-19).Original consent in French.The participant information materials and informed consent form are available from the corresponding author on request.
: Original consent in French.The participant information materials and informed consent form are available from the corresponding author on request. This does not apply to the current manuscript—no patient data is included.
: The authors declare that the protocol was created in the absence of any commercial or financial relationships that could be construed as potential conflict of interest.